A ccording to preliminary estimates, Light Vehicle (LV) sales grew by 2.4% year-on-year (YoY) in December, to 1.51 million ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

Operational risks are also reduced due to a lesser need for human intervention in hazardous environments, which is a very ...

Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...